2抑制剂-话题@MedSci

#2抑制剂#

221篇内容 | 4145人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1995661, encodeId=eeaa199566180, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Cardiovasc Diabetol：DPP-4抑制剂、GLP-1受体激动剂和SGLT-2抑制剂对心肾结局的影响, objectType=article, longId=723796, objectId=c62be2379617, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c62be2379617, replyNumber=0, likeNumber=81, createdTime=2022-10-27, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c62be2379617, moduleTitle=Cardiovasc Diabetol：DPP-4抑制剂、GLP-1受体激动剂和SGLT-2抑制剂对心肾结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c62be2379617)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995643, encodeId=ba751995643bd, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Diabetes Obes Metab：SGLT-2抑制剂对T2DM患者血清尿酸水平的影响, objectType=article, longId=218712, objectId=149f218e125c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=149f218e125c, replyNumber=0, likeNumber=83, createdTime=2022-08-20, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=149f218e125c, moduleTitle=Diabetes Obes Metab：SGLT-2抑制剂对T2DM患者血清尿酸水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=149f218e125c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995649, encodeId=b82d199564921, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Diabetes Obes Metab：肾血流动力学对SGLT-2抑制剂的反应不依赖于蛋白质摄入量, objectType=article, longId=219913, objectId=119c21991317, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=119c21991317, replyNumber=0, likeNumber=69, createdTime=2022-03-03, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=119c21991317, moduleTitle=Diabetes Obes Metab：肾血流动力学对SGLT-2抑制剂的反应不依赖于蛋白质摄入量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=119c21991317)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995648, encodeId=0622199564878, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Drugs：SGLT-2抑制剂在治疗非糖尿病性慢性肾病中的作用, objectType=article, longId=219863, objectId=fc9021986320, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc9021986320, replyNumber=0, likeNumber=0, createdTime=2022-06-23, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc9021986320, moduleTitle=Drugs：SGLT-2抑制剂在治疗非糖尿病性慢性肾病中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc9021986320)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995655, encodeId=e2351995655b1, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Diabetes Care:钠-葡萄糖共转运蛋白2抑制剂、二肽基肽酶4抑制剂和磺酰脲类药物对糖尿病酮症酸中毒风险的安全性比较, objectType=article, longId=299394, objectId=4c1a29939490, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c1a29939490, replyNumber=0, likeNumber=120, createdTime=2022-10-05, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c1a29939490, moduleTitle=Diabetes Care:钠-葡萄糖共转运蛋白2抑制剂、二肽基肽酶4抑制剂和磺酰脲类药物对糖尿病酮症酸中毒风险的安全性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c1a29939490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995638, encodeId=af76199563874, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Diabetes Care：2型糖尿病患者SGLT2抑制剂与视网膜静脉阻塞风险的关系, objectType=article, longId=214922, objectId=a0cf214922cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0cf214922cb, replyNumber=0, likeNumber=76, createdTime=2021-12-29, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0cf214922cb, moduleTitle=Diabetes Care：2型糖尿病患者SGLT2抑制剂与视网膜静脉阻塞风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0cf214922cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995645, encodeId=787e199564592, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Lancet子刊：新型降糖药SGLT2抑制剂达格列净能明显保护糖尿病肾病！, objectType=article, longId=218938, objectId=389521893854, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=389521893854, replyNumber=0, likeNumber=104, createdTime=2022-02-13, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=389521893854, moduleTitle=Lancet子刊：新型降糖药SGLT2抑制剂达格列净能明显保护糖尿病肾病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=389521893854)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995647, encodeId=8dd5199564efb, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Mol Metab：钠-葡萄糖共转运体2抑制剂在糖尿病动脉粥样硬化斑块中的表达和炎症活动, objectType=article, longId=219808, objectId=93ce219808c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93ce219808c2, replyNumber=0, likeNumber=111, createdTime=2022-06-30, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93ce219808c2, moduleTitle=Mol Metab：钠-葡萄糖共转运体2抑制剂在糖尿病动脉粥样硬化斑块中的表达和炎症活动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93ce219808c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995662, encodeId=0c1619956625c, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Ann Intern Med：心衰患者钠-葡萄糖共转运蛋白2抑制剂的效果分析, objectType=article, longId=724158, objectId=a7abe24158f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7abe24158f2, replyNumber=0, likeNumber=86, createdTime=2022-10-29, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7abe24158f2, moduleTitle=Ann Intern Med：心衰患者钠-葡萄糖共转运蛋白2抑制剂的效果分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7abe24158f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995657, encodeId=3ebb199565e0b, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Cardiovasc Diabetol：GLP-1激动剂 vs SGLT-2抑制剂 vs DPP-4抑制剂对T2DM患者心肾结局的影响, objectType=article, longId=301367, objectId=c4b830136e91, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4b830136e91, replyNumber=0, likeNumber=66, createdTime=2022-08-09, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4b830136e91, moduleTitle=Cardiovasc Diabetol：GLP-1激动剂 vs SGLT-2抑制剂 vs DPP-4抑制剂对T2DM患者心肾结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4b830136e91)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995633, encodeId=8759199563309, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=BMJ：重磅！冠脉重建后DAPT治疗的核心地位被动摇，P2Y12抑制剂单药治疗或收益更大, objectType=article, longId=212913, objectId=5ce1212913f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ce1212913f0, replyNumber=0, likeNumber=0, createdTime=2022-02-09, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ce1212913f0, moduleTitle=BMJ：重磅！冠脉重建后DAPT治疗的核心地位被动摇，P2Y12抑制剂单药治疗或收益更大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ce1212913f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995637, encodeId=07ae199563efb, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=降糖药SGLT-2抑制剂也能治心衰？看完本文马上掌握！, objectType=article, longId=214626, objectId=4e1d214626dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e1d214626dd, replyNumber=0, likeNumber=85, createdTime=2022-01-01, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e1d214626dd, moduleTitle=降糖药SGLT-2抑制剂也能治心衰？看完本文马上掌握！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e1d214626dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995640, encodeId=aa1b1995640e1, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=勤浩医药SHP2抑制剂GH21完成中美双报IND, objectType=article, longId=216513, objectId=c0e7216513c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0e7216513c3, replyNumber=0, likeNumber=66, createdTime=2021-11-10, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0e7216513c3, moduleTitle=勤浩医药SHP2抑制剂GH21完成中美双报IND, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0e7216513c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995644, encodeId=ef71199564455, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Lancet Oncol：IDH2抑制剂Enasidenib联合阿扎胞苷治疗IDH2突变型急性髓系白血病的疗效和安全性, objectType=article, longId=218905, objectId=80032189050a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80032189050a, replyNumber=0, likeNumber=87, createdTime=2021-11-29, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80032189050a, moduleTitle=Lancet Oncol：IDH2抑制剂Enasidenib联合阿扎胞苷治疗IDH2突变型急性髓系白血病的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80032189050a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995646, encodeId=2808199564669, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Nat Med：SGLT2抑制剂达格列净治疗射血分数正常心衰的效果, objectType=article, longId=219505, objectId=2f0321950544, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f0321950544, replyNumber=0, likeNumber=0, createdTime=2022-01-23, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f0321950544, moduleTitle=Nat Med：SGLT2抑制剂达格列净治疗射血分数正常心衰的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f0321950544)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995651, encodeId=72fe19956511a, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=JCEM：钠-葡萄糖协同转运蛋白2抑制剂对左心室功能的有益作用, objectType=article, longId=221645, objectId=82d222164590, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82d222164590, replyNumber=0, likeNumber=75, createdTime=2022-03-25, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82d222164590, moduleTitle=JCEM：钠-葡萄糖协同转运蛋白2抑制剂对左心室功能的有益作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82d222164590)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995652, encodeId=131019956526f, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=BMJ子刊：SGLT-2抑制剂会造成肾损伤吗？这项2万多人的队列研究告诉你答案！, objectType=article, longId=292226, objectId=5d56292226bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d56292226bc, replyNumber=0, likeNumber=89, createdTime=2022-11-08, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d56292226bc, moduleTitle=BMJ子刊：SGLT-2抑制剂会造成肾损伤吗？这项2万多人的队列研究告诉你答案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d56292226bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995636, encodeId=c3a319956366e, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Heart：阿司匹林与P2Y12抑制剂联合抗凝治疗对房颤的疗效分析, objectType=article, longId=214509, objectId=d98d214509a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d98d214509a2, replyNumber=0, likeNumber=83, createdTime=2021-11-30, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d98d214509a2, moduleTitle=Heart：阿司匹林与P2Y12抑制剂联合抗凝治疗对房颤的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d98d214509a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995650, encodeId=cdfb199565081, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=JAMA子刊：SGLT2抑制剂与2型糖尿病和痛风发病率的关系, objectType=article, longId=220869, objectId=83b52208691b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83b52208691b, replyNumber=0, likeNumber=80, createdTime=2022-04-25, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83b52208691b, moduleTitle=JAMA子刊：SGLT2抑制剂与2型糖尿病和痛风发病率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83b52208691b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995642, encodeId=af31199564288, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Ann Intern Med：SGLT2抑制剂 vs GLP-1 RA对有无CVD的T2D患者心血管事件风险的影响, objectType=article, longId=218049, objectId=35582180496e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35582180496e, replyNumber=0, likeNumber=104, createdTime=2021-10-23, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35582180496e, moduleTitle=Ann Intern Med：SGLT2抑制剂 vs GLP-1 RA对有无CVD的T2D患者心血管事件风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35582180496e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2抑制剂

2020-05-29

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Cardiovasc Diabetol：DPP-4抑制剂、GLP-1受体激动剂和SGLT-2抑制剂对心肾结局的影响

2022-10-27

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Diabetes Obes Metab：SGLT-2抑制剂对T2DM患者血清尿酸水平的影响

2022-08-20

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Diabetes Obes Metab：肾血流动力学对SGLT-2抑制剂的反应不依赖于蛋白质摄入量

2022-03-03

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Drugs：SGLT-2抑制剂在治疗非糖尿病性慢性肾病中的作用

2022-06-23

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Diabetes Care:钠-葡萄糖共转运蛋白2抑制剂、二肽基肽酶4抑制剂和磺酰脲类药物对糖尿病酮症酸中毒风险的安全性比较

2022-10-05

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Diabetes Care：2型糖尿病患者SGLT2抑制剂与视网膜静脉阻塞风险的关系

2021-12-29

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Lancet子刊：新型降糖药SGLT2抑制剂达格列净能明显保护糖尿病肾病！

2022-02-13

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Mol Metab：钠-葡萄糖共转运体2抑制剂在糖尿病动脉粥样硬化斑块中的表达和炎症活动

2022-06-30

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Ann Intern Med：心衰患者钠-葡萄糖共转运蛋白2抑制剂的效果分析

2022-10-29

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Cardiovasc Diabetol：GLP-1激动剂 vs SGLT-2抑制剂 vs DPP-4抑制剂对T2DM患者心肾结局的影响

2022-08-09

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

BMJ：重磅！冠脉重建后DAPT治疗的核心地位被动摇，P2Y12抑制剂单药治疗或收益更大

2022-02-09

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

降糖药SGLT-2抑制剂也能治心衰？看完本文马上掌握！

2022-01-01

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

勤浩医药SHP2抑制剂GH21完成中美双报IND

2021-11-10

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Lancet Oncol：IDH2抑制剂Enasidenib联合阿扎胞苷治疗IDH2突变型急性髓系白血病的疗效和安全性

2021-11-29

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Nat Med：SGLT2抑制剂达格列净治疗射血分数正常心衰的效果

2022-01-23

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

JCEM：钠-葡萄糖协同转运蛋白2抑制剂对左心室功能的有益作用

2022-03-25

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

BMJ子刊：SGLT-2抑制剂会造成肾损伤吗？这项2万多人的队列研究告诉你答案！

2022-11-08

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Heart：阿司匹林与P2Y12抑制剂联合抗凝治疗对房颤的疗效分析

2021-11-30

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

JAMA子刊：SGLT2抑制剂与2型糖尿病和痛风发病率的关系

2022-04-25

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Ann Intern Med：SGLT2抑制剂 vs GLP-1 RA对有无CVD的T2D患者心血管事件风险的影响

2021-10-23

科室
- - 订阅+
  - 更多科室
工具
服务